News and Insights

Jenner & Block Builds on Strength of Antitrust Practice with Return of Shaun Van Horn

Jenner & Block is pleased to announce that Shaun Van Horn, a seasoned litigator with extensive experience in intellectual property, antitrust, and complex commercial disputes, has returned to Jenner & Block as a Partner in its Chicago office. Shaun rejoins Jenner’s nationally recognized Business Litigation and Antitrust and Competition Law Practices, bringing with him a proven track record in antitrust, patent, and commercial litigation....READ MORE

Jenner & Block’s London Office Almost Doubles Office Space with Move

LONDON, 1STNovember, 2022– International law firm Jenner & Block has completed the relocation of its growing London team to new offices at 10 Exchange Square, Broadgate, in the heart of the City....READ MORE

Recent Rulings Highlight Risk to Japanese Drugmakers in Settling Pharmaceutical Litigations

In FTC v. Actavis, Inc., 570 U.S. 136 (2013), the US Supreme Court addressed the legality of “reverse payment” settlements in pharmaceutical patent litigation. A reverse payment occurs when a brand-name drug manufacturer pays a generic drug manufacturer to settle patent litigation and delay the generic’s market entry, essentially paying the potential competitor not to compete. Since Actavis, pharmaceutical companies’ settlements have become more complex, often finding ways to provide value to ge...READ MORE

Client Alert: Supreme Court Affirms High Enablement Bar for Drug Patents

On May 18, 2023, the Supreme Court affirmed the Federal Circuit’s (CAFC) decision on enablement in Amgen Inc. v. Sanofi, 987 F.3d 1080 (CA Fed. 2021). The Court thus left in place a significant decision making it more difficult for drug companies to block competitive products that are functionally equivalent, but structurally different. In particular, the Court held that the Federal Circuit’s approach to determining enablement in functional genus claims is consistent with the statute and Supreme...READ MORE

Contributing Editors and Authors, Lexology’s Patents 2023

Partners Louis Fogel and Shaun Van Horn and Associate Paaras Modi were the contributing editors for Patents 2023 and wrote “Patents: USA,” which offers a comprehensive break-down of key topics in US patent law including enforcement proceedings, scope and ownership, defenses, remedies, licensing, patent office proceedings, and updates and trends. They also wrote “Patents: Global Overview,” which highlights key evolutions in patent law around the world last year. Patents 2023 is published by Lexol...READ MORE